MedPath

Impact of Meal Order on Postprandial Cardiometabolic Risk Markers

Not Applicable
Completed
Conditions
Metabolic Syndrome X
Hyperinsulinism
Metabolic Diseases
Insulin Resistance
Glucose Metabolism Disorders
Registration Number
NCT03358745
Lead Sponsor
Lund University
Brief Summary

The order in which the different components of a meal are eaten may have impact on the postprandial metabolic responses to carbohydrates, fat and proteins. This study will compare blood lipids and glycemia regulation following lunches of identical composition but varying the order of intake of the different meal components.

Detailed Description

The order in which the different components of a meal are eaten may have impact on the postprandial metabolic responses to carbohydrates, fat and proteins. Some of these responses are associated with the risk for developing cardiometabolic complications.

The study will be carried out in a cohort of healthy subjects with a wide BMI range and normal fasting glycemia. Postprandial metabolic responses to a reference meal starting with bread and butter (BB) will be compared with those registered after 3 other meals of identical composition, in which the starter will be permutated. Each meal is tested on an independent experimental session, with a 1 week washout interval.

The intervention will be carried out at the Food for Health Science Centre - Lund University. Additionally, the plan contemplates an initial information visit including screening of fasting blood glucose. In total, each volunteer completing the study will pay five visits to the clinical unit.

Based on the results from the above-described phase, a second step of the study will compare various quality attributes of the most effective starter on the impact on cardiometabolic risk markers, as a way to optimize putative protective actions and to gain further mechanistic insight.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • BMI between 20 and 30 kg/m2
  • Fasting blood glucose ≤ 6.1 mmol/L
  • No known medical condition
Exclusion Criteria
  • Smoking habits
  • Treatment for high blood pressure
  • Treatment for hypercholesterolemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Area under the curve of postprandial glycemia4 hours postprandial

Area under the curve of postprandial glycemia (0-4h) after each intervention, compared to the reference meal.

Plasma glucose is measured pre-meal and and at various post-meal intervals for up to for 4 hours. AUC is calculated and compared to AUC recorded after the reference meal.

Secondary Outcome Measures
NameTimeMethod
Area under the curve (AUC) of postprandial triglyceridemia4 hours postprandial

Area under the curve (AUC) of postprandial triglyceridemia (0-4h) after each intervention, compared to the reference meal

Area under the curve (AUC) of postprandial insulinemia4 hours postprandial

Area under the curve (AUC) of postprandial insulinemia (0-4h) after each intervention, compared to the reference meal

Area under the curve (AUC) of postprandial Glucagon-like peptide (GLP-1), Peptide YY (PYY) and glucose-dependent insulinotropic polypeptide (GIP)4 hours

Area under the curve (AUC) of postprandial GLP-1, GIP and PYY (0-4h) after each intervention, compared to the reference meal

Trial Locations

Locations (2)

Antidiabetic Food Centre, Chemical Centre. Lund University

🇸🇪

Lund, Skane, Sweden

Food for Health Science Centre. Lund University Medicon Village

🇸🇪

Lund, Sweden

Antidiabetic Food Centre, Chemical Centre. Lund University
🇸🇪Lund, Skane, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.